TY - JOUR
T1 - Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats
AU - Higa, Moritake
AU - Zhou, Yan Ting
AU - Ravazzola, Mariella
AU - Baetens, Danielle
AU - Orci, Lelio
AU - Unger, Roger H
PY - 1999/9/28
Y1 - 1999/9/28
N2 - To determine whether the antidiabetic action of troglitazone (TGZ), heretofore attributed to insulin sensitization, also involves protection of β cells from lipoapoptosis, we treated prediabetic Zucker Diabetic Fatty rats with 200 mg/kg per day of TGZ. Their plasma-free fatty acids and triacylglycerol fell to 1.3 mM and 111 mg/dl, respectively, compared with 2.0 mM and 560 mg/dl in untreated controls. Their islet triacylglycerol content was 34% below controls. In islets of control rats, β cells were reduced by 82% and the islet architecture was disrupted; β-cell glucose transporter-2 was absent, 85% of their mitochondria were altered, and they were unresponsive to glucose. In treated rats, the loss of β cells was prevented, as were the loss of β cell glucose transporter-2, the mitochondrial alterations, and the impairment of glucose-stimulated insulin secretion. We conclude that the antidiabetic effect of TGZ in prediabetic Zucker Diabetic Fatty rats involves prevention of lipotoxicity and lipoapoptosis of β cells, as well as improvement in insulin sensitivity.
AB - To determine whether the antidiabetic action of troglitazone (TGZ), heretofore attributed to insulin sensitization, also involves protection of β cells from lipoapoptosis, we treated prediabetic Zucker Diabetic Fatty rats with 200 mg/kg per day of TGZ. Their plasma-free fatty acids and triacylglycerol fell to 1.3 mM and 111 mg/dl, respectively, compared with 2.0 mM and 560 mg/dl in untreated controls. Their islet triacylglycerol content was 34% below controls. In islets of control rats, β cells were reduced by 82% and the islet architecture was disrupted; β-cell glucose transporter-2 was absent, 85% of their mitochondria were altered, and they were unresponsive to glucose. In treated rats, the loss of β cells was prevented, as were the loss of β cell glucose transporter-2, the mitochondrial alterations, and the impairment of glucose-stimulated insulin secretion. We conclude that the antidiabetic effect of TGZ in prediabetic Zucker Diabetic Fatty rats involves prevention of lipotoxicity and lipoapoptosis of β cells, as well as improvement in insulin sensitivity.
KW - Lipoapoptosis
KW - Lipotoxicity
KW - Zucker Diabetic Fatty rats
UR - http://www.scopus.com/inward/record.url?scp=0033613181&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033613181&partnerID=8YFLogxK
U2 - 10.1073/pnas.96.20.11513
DO - 10.1073/pnas.96.20.11513
M3 - Article
C2 - 10500208
AN - SCOPUS:0033613181
SN - 0027-8424
VL - 96
SP - 11513
EP - 11518
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 20
ER -